How to Draw the Attention of a College Hockey Coach

An accomplished financial executive, Warren Lammert is the founder, chief executive officer, and chief investment officer at Granite Point Capital, a Boston, Massachusetts-based investment firm. Before launching his career and founding Granite Point Capital, Warren Lammert earned a master’s degree from the London School of Economics and Political Science and bachelor’s degree from Yale University, where he served as a member of the junior varsity ice hockey team.

While it can prove difficult to land a spot on a college hockey team, there are some ways that people can be proactive and attract a college hockey coach’s attention. First, they can proactively reach out to coaches. Typically, college scouts do not contact high school players until they have completed the 10th-grade year. However, players can start building name recognition and relationships with college coaches at any time. They can consider sending prospective coaches their hockey resume and inviting these individuals to watch them play.

Another tip to make a college hockey team is to show that you can perform well academically. To become eligible for NCAA sports, you need to maintain a high grade point average and pass a standardized test. Lastly, make sure that your commitment to good sportsmanship always shines through.

The Important Role of Venture Capital

The founder, CEO, and chief investment officer of the Boston-based investment firm Granite Point Capital, Warren Lammert draws on 30 years of experience. In addition to his work at Granite Point Capital, Warren Lammert possesses an interest in a wide range of financial topics that include venture capital.

Venture capital serves an important role in the economy. When a new technology, product, or service is developed, its creators often have few institutional funding options. Since the risks inherent in startups would demand higher interest rates on bank loans than is allowed by law, the only other option for traditional bankers would be to seek hard assets as collateral to secure the debt.

Since few startups have hard assets, venture capital fills the void. In order for venture capital investors to be successful, they must earn a sufficient return on their capital investment. This incentive helps venture capitalists to attract private equity funds to fund high-quality ideas.

Chartered Financial Analyst Institute Offers Ethics Content Online

An accomplished finance executive, Warren Lammert serves as the CEO and chief investment officer of Granite Point Capital, a Boston-based hedge fund. With more than 15 years of experience managing Granite Point Capital, Warren Lammert is a CFA® charterholder with the Chartered Financial Analyst (CFA) Institute.

The leading global professional association for investment management professionals, the CFA Institute offers a variety of learning opportunities and the chance for finance professionals to earn continuing education credits. Moreover, it features an Ethics in Practice series, which allows participants to explore their ethical decision-making skills through a case study drawn from real-world circumstances.

Participants are given details of the case, as well as possible responses to the ethical conundrum. The interactive activity asks participants to assess the case using the CFA Institute Ethical Decision-Making Framework and Code of Ethics and Standards of Professional Conduct. You can search the institute’s website to find a compilation of more than 100 previously published financial ethics cases and corresponding analyses.

A New Breakthrough in the Field of Gene Therapy

A noted philanthropist and businessman, Warren Lammert functions as the CEO and chief investment officer of Granite Point Capital, a Boston hedge fund that he founded. Warren Lammert also co-founded Tevard Biosciences, a startup that develops innovative gene therapies to treat rare conditions.

A process that introduces new genetic material into the body’s cells to block the effects of abnormal genes, gene therapy holds a lot of potential for improving therapies and treatments for genetic disorders, cancer, and other diseases. A recent study published in Science Translational Medicine reported that researchers were able to edit the genetic makeup of a specialized subset of adult blood stem cells for the first time.

The study’s findings suggest that there may be a more efficient way to modify stem cells, a process that has the potential to significantly reduce the costs of gene-editing treatments for blood disorders and other diseases, as well as the negative side effects. “Targeting this portion of stem cells could potentially help millions of people with blood diseases,” said senior study author Dr. Hans-Peter Kiem, a member of the Clinical Research Division at the Fred Hutchinson Cancer Research Center.